Category : Search result: pharmaceutical firms


Market Cap of 7 Top-10 Firms Surges Rs 1.23 Lakh Crore

The combined market valuation of seven of India's top-10 most valued firms jumped by Rs 1,23,290.77 crore last week, with Reliance Industries emerging as the biggest gainer. Discover which stocks drove the rally.

Law Firms Prep for Deep AI Integration in 2026

Top Indian law firms are moving beyond AI pilots to redesign core legal workflows in 2026 for speed and accuracy, while navigating billing shifts and Supreme Court scrutiny. Explore the transformation.

Top Firms Add Rs 75,257 Cr Market Cap; TCS, Infosys Gain

Six of India's top 10 most valued firms added Rs 75,257 crore in market capitalisation last week. TCS and Infosys were the biggest gainers, while Reliance Industries saw a decline. Discover the key drivers and stock market trends.

Sudeep Pharma IPO Subscribed 94 Times

Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.

Ramaswamy's net worth jumps 80% to $1.8 billion

Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.

7 Top Firms Gain Rs 1.28 Lakh Crore in Market Cap

Seven of India's top 10 companies saw massive market cap surge of Rs 1.28 lakh crore last week. Reliance Industries and Bharti Airtel emerged as biggest gainers in stellar market performance.

Balaxi Pharma Soars 10% Despite 47% Yearly Loss

Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.

Page 1 of 4